WELL Health Technologies Corp.
TSX:WELL.TOMedical - Care Facilities
+$0.02 today
- Market cap
- $947.00M
- Beta
- 1.33
- P/E (TTM)
- 41.6
- EPS (TTM)
- $0.11
Volume 2.80M
Average 1.62M
WELL.TO EBITDA Margin
EBITDA as a percentage of revenue.
WELL Health Technologies Corp.TSX: WELL.TO
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to 12.3%
EBITDA Margin was 12.3% in Q1 FY2026, up 16.6 pp from a year earlier. On a trailing-twelve-month basis it was 14.9%, up 8.6 pp year over year. Over 3 fiscal years it narrowed by 1.9 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 14 analysts of 58.4% for the fiscal year ending Dec 2026, up from 14.8% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 12.3%-3.7 pp QoQ
- Last fiscal yearDec 2025
- 14.8%+1.4 pp YoY
- LTMMar 2026
- 14.9%+8.6 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +16.6 pp | +1.0 pp | -15.6 pp |
| 1 year | +1.4 pp | +43.6 pp | +42.2 pp |
| 3 years | -1.9 pp | +67.8 pp | +69.7 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 14.8%
- Year-over-year change
- +1.4pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.8% | +1.4pp |
| FY2024 | 2024-12-31 | 13.3% | +0.2pp |
| FY2023 | 2023-12-31 | 13.1% | -3.6pp |
| FY2022 | 2022-12-31 | 16.7% | +9.7pp |
| FY2021 | 2021-12-31 | 7.0% | — |
EBITDA Margin vs competitors
How WELL.TO compares with its peers on the latest reported figures
- WELL.TO's LTM Mar 2026 EBITDA Margin of 14.9% is the 4th highest of the 5 companies compared; the peer median is 21.5%.
- Its year-over-year change of +8.6 pp is the 2nd highest of 5, against a peer median of +1.5 pp.
- Over three fiscal years its change of -1.9 pp compares with a peer median of +8.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 30.0% | +45.0 pp | +105.2 pp | |
| LTM Mar 2026 | 24.7% | -1.0 pp | +10.9 pp | |
| LTM Sep 2026 | 18.3% | +3.3 pp | +1.9 pp | |
| LTM Mar 2026 | 14.9% | +8.6 pp | -1.9 pp | |
| LTM Jun 2026 | 10.8% | -0.2 pp | +6.5 pp | |
| Peer median (excluding WELL.TO) | 21.5% | +1.5 pp | +8.7 pp | |
Competitors are the stored peer set for WELL.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 302.32M | 569.14M | 776.05M | 919.69M | 1.4B |
| Cost of Revenue | 148.63M | 265.85M | 403.79M | 556.68M | 875.1M |
| Gross Profit | 153.7M | 303.29M | 372.27M | 363.01M | 525.08M |
| Gross Margin | 50.8% | 53.3% | 48.0% | 39.5% | 37.5% |
| Research & Development | 0 | 3.15M | 3.46M | 0 | 0 |
| Selling, General & Admin | 123.52M | 224.11M | 276.98M | 321.47M | 432.38M |
| Operating Expenses | 161.74M | 279.31M | 337.11M | 393.21M | 412.05M |
| Depreciation & Amortization | 38.71M | 55.2M | 60.77M | 72.31M | 93.76M |
| EBITDA | 21.27M | 95.07M | 101.88M | 122.52M | 206.79M |
| EBITDA Margin | 7.0% | 16.7% | 13.1% | 13.3% | 14.8% |
| Operating Income | (6.21M) | 23.31M | 35.16M | (30.2M) | 113.03M |
| Operating Margin | -2.1% | 4.1% | 4.5% | -3.3% | 8.1% |
| Interest Income | 555K | 649K | 763K | 1.27M | 1.72M |
| Interest Expense | 7.84M | 22.86M | 32.32M | 36.88M | 54.47M |
| Other Income / Expenses | (11.99M) | (5.79M) | (15.66M) | 39.19M | (107.72M) |
| Income Before Tax | (24.77M) | 17.92M | 19.5M | 8.99M | 5.31M |
| Pre-Tax Margin | -8.2% | 3.1% | 2.5% | 1.0% | 0.4% |
| Income Tax Expense | 5.92M | (1.15M) | 2.86M | (20.1M) | 846K |
| Net Income | (30.69M) | 19.07M | 82K | 32.61M | (50.21M) |
| Net Margin | -10.2% | 3.4% | 0.0% | 3.5% | -3.6% |
| EPS (Basic) | (0.16) | 0.09 | 0.00 | 0.13 | (0.03) |
| EPS (Diluted) | (0.16) | 0.09 | 0.00 | 0.13 | (0.03) |
| Weighted Avg Shares | 190.9M | 220.69M | 236.54M | 246.76M | 1.67B |
| Weighted Avg Shares (Diluted) | 190.9M | 220.69M | 236.54M | 254.65M | 1.73B |
WELL Health Technologies Corp.
TSX:WELL.TO
Intrinsic Alpha fair value
Locked
Current Price
$3.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.